CN Patent

CN121487913A — 制备本维莫德的方法

Assigned to Interquim SA · Expires 2026-02-06 · 0y expired

What this patent protects

本发明涉及一种制备本维莫德（Tapinarof）的方法，以及本维莫德的新型共晶体和溶剂化物、其制备方法及其在获得高收率纯本维莫德方面的应用。

USPTO Abstract

本发明涉及一种制备本维莫德（Tapinarof）的方法，以及本维莫德的新型共晶体和溶剂化物、其制备方法及其在获得高收率纯本维莫德方面的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN121487913A
Jurisdiction
CN
Classification
—
Expires
2026-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Interquim SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.